Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Ambati V. Raghava Reddy"'
Autor:
Raghubabu Korupolu, Ambati V. Raghava Reddy, Paul Douglas Sanasi, Srinivas Garaga, N. V. D. Harikiran Maddi
Publikováno v:
Current Issues in Pharmacy and Medical Sciences, Vol 30, Iss 1, Pp 31-35 (2017)
Azilsartan Kamedoxomil is an AT1-subtype angiotensin II receptor blocker (ARB). During the laboratory synthesis of Azilsartan Kamedoxomil, four related substances of Azilsartan Kamedoxomil were observed and identified. These were 2-Ethoxy-3-[[4-[2- [
Autor:
Chandiran Takshinamoorthy, Garaga Srinivas, Badarinadh Gupta Peruri, Ambati V. Raghava Reddy, Andra Naidu
Publikováno v:
Scientia Pharmaceutica
Volume 84
Issue 3
Pages 447-455
Volume 84
Issue 3
Pages 447-455
This paper describes the facile synthesis of sildenafil citrate (1) and its related compounds through an improved chlorosulfonation reaction using chlorosulfonic acid and thionyl chloride. This synthesis results in pure sildenafil with high yield. Th
Autor:
Chandiran Takshinamoorthy, Paul Douglas Sanasi, Raghubabu Korupolu, Koilpillai Joseph Prabahar, Srinivas Garaga, Ambati V. Raghava Reddy, Nimesh C. Misra
Publikováno v:
Current Issues in Pharmacy and Medical Sciences, Vol 28, Iss 2, Pp 72-76 (2015)
This paper provides a description of an alternative, novel and commercially viable process which has been developed for the preparation of Azilsartan, a pro-drug of Azilsartan medoxomil, an angiotensin II receptor blocker. The present work also provi
Autor:
Nimesh C. Misra, Korupolu Raghu Babu, Ambati V. Raghava Reddy, Chandiran Takshinamoorthy, Paul Douglas Sanasi, Srinivas Garaga, Koilpillai Joseph Prabahar
Publikováno v:
Organic Process Research & Development. 19:514-519
A commercially viable process for the preparation of azilsartan kamedoxomil, an angiotensin II receptor blocker, has been developed. The present work describes the novel synthesis of azilsartan medoxomil from amidoxime methyl ester. The present work
Publikováno v:
Scientia Pharmaceutica
Volume 83
Issue 1
Pages 49-63
Volume 83
Issue 1
Pages 49-63
Lopinavir is an antiretroviral drug used for the inhibition of HIV protease. Four related substances of lopinavir were observed during the manufacturing process of lopinavir in the laboratory and they were identified. The present work describes the o
Autor:
Chandiran Takshinamoorthy, Ambati V Raghava Reddy, Ramesh Dandala, Andra Naidu, Srinivas Garaga
Publikováno v:
Scientia Pharmaceutica
Volume 84
Issue 2
Pages 269-278
Volume 84
Issue 2
Pages 269-278
Lisinopril is a drug of the angiotensin-converting enzyme (ACE) inhibitor class that is primarily used in the treatment of hypertension. During the scale-up of the lisinopril process, one unknown impurity was observed and is identified. The present w
Autor:
Ambati V. Raghava Reddy, Raghu Babu Korupolu, Srinivas Garaga, Koilpillai Joseph Prabahar, Paul Douglas Sanasi
Publikováno v:
Scientia Pharmaceutica
Volume 81
Issue 3
Pages 651-662
Volume 81
Issue 3
Pages 651-662
Gatifloxacin is an antibacterial agent belonging to the fourth-generation fluoroquinolone family. Four piperazine-linked fluoroquinolone dimers of Gatifloxacin were observed during the laboratory process for Gatifloxacin and they were identified. The
Autor:
Srinivas Garaga, NimeshC. Misra, Ambati V. Raghava Reddy, Koilpillai Joseph Prabahar, Chandiran Takshinamoorthy, Paul Douglas Sanasi, Korupolu Raghu Babu
Publikováno v:
Organic Process Research & Development; Apr2015, Vol. 19 Issue 4, p514-519, 6p
Autor:
Korrapati venkata vara Prasada Rao, Koilpillai Joseph Prabahar, Garaga Srinivas, Paul Douglas Sanasi, Raghubabu Korupolu, Ambati V. Raghava Reddy
Publikováno v:
Sustainable Chemical Processes. 2(1):2
An improved, cost effective process for the synthesis of N,N-diisopropyl-3-(2-hydroxy-5-methylphenyl)-3-phenylpropanamide; a key intermediate for the preparation of Tolterodine and its related substances were described. The process features one pot s
Autor:
Maddi, N. V. D. Harikiran1, Garaga, Srinivas1, Reddy, Ambati V. Raghava1, Sanasi, Paul Douglas1, Korupolu, Raghubabu1
Publikováno v:
Current Issues in Pharmacy & Medical Sciences. Mar2017, Vol. 30 Issue 1, p31-35. 5p.